Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Invasive Evaluation of Pulmonary Artery Stenosis in Congenital Heart Disease Patients Using Phase Contrast MRI.

Cardiovascular engineering and technology·2026
Same author

Frequent Plasmodium ovale recurrence in coastal Tanzania.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Assessing Fab-Functionalized Gold Nanoparticles-Mediated Thermal Enhancement during High-Intensity Focused Ultrasound Ablation in a Mouse Tumor Model.

ACS applied bio materials·2025
Same author

Seasonal Variation and Interspecies Dynamics Among Plasmodium falciparum and ovale Species in Bagamoyo, Tanzania.

The Journal of infectious diseases·2025
Same author

The effect of particle seeding on the rheological properties of blood Analog fluid used during laser Doppler velocimetry.

Biorheology·2025
Same author

Seasonal variation and interspecies dynamics among <i>Plasmodium falciparum</i> and <i>ovale</i> species in Bagamoyo, Tanzania.

medRxiv : the preprint server for health sciences·2025
Same journal

Metformin and Flutamide Combination Therapy's Efficacy and Safety in Prostate Cancer Cell Lines.

Prostate cancer·2026
Same journal

In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines.

Prostate cancer·2026
Same journal

Determinants of the Cost of Illness in Iranian Prostate Cancer Patients.

Prostate cancer·2026
Same journal

The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells.

Prostate cancer·2026
Same journal

Real-World Treatment Patterns Before and After Metastatic Castration-Resistant Prostate Cancer in Japan: Retrospective Analysis Using a Hospital-Based, Multicenter Database.

Prostate cancer·2026
Same journal

Correlating Histological Results and Total Serum Levels of the Prostate-Specific Antigen Among Patients in Southwestern Uganda.

Prostate cancer·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.9K

Development of Mouse-Tumor Model Using Prostate Cancer (PC3) Cell Line for High-Intensity Focused Ultrasound (HIFU)

Nabin Khanal1, Victoria Summey2, Jeffrey Bailey2

  • 1Department of Mechanical and Materials Engineering, University of Cincinnati, Cincinnati, Ohio, USA.

Prostate Cancer
|September 15, 2025
PubMed
Summary
This summary is machine-generated.

NSG mice are the best breed for high-intensity focused ultrasound (HIFU) prostate cancer research due to superior tumor growth. This model is validated for HIFU ablation studies, showing increased cell death.

Keywords:
HIFUPC3mouse-tumor modelnoninvasiveprostate cancerultrasound

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K

Related Experiment Videos

Last Updated: Jan 17, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.9K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Preclinical Research

Background:

  • High-intensity focused ultrasound (HIFU) is a promising noninvasive cancer treatment.
  • Mouse models are crucial for HIFU research, but breed selection impacts tumor consistency.
  • Tumor size and growth rate are critical factors for experimental success.

Purpose of the Study:

  • To identify the optimal mouse breed for consistent, sizable tumor growth in preclinical HIFU studies.
  • To evaluate the suitability of NSG mice for HIFU ablation of prostate cancer.
  • To validate the chosen mouse model for future HIFU research.

Main Methods:

  • Three mouse breeds (NSG, NSGS, Nude) were implanted with human PC3 prostate cancer cells.
  • Tumor surface area and volume were measured over 5-7 weeks.
  • NSG mice were subsequently used for HIFU ablation experiments with histopathological analysis.

Main Results:

  • NSG mice demonstrated significantly larger tumor surface area (up to 58%) and volume (up to 100%) compared to NSGS and Nude mice.
  • HIFU treatment in NSG mice resulted in a significantly higher number of apoptotic cells.
  • Tumor dimensions were consistent between initial testing and the larger sample size group.

Conclusions:

  • NSG mice are the superior breed for PC3-induced tumor growth within a 5-7 week timeline for HIFU research.
  • The NSG mouse model is validated for HIFU ablation, showing efficacy in inducing tumor cell death.
  • This study provides a robust preclinical model for advancing HIFU cancer therapy.